Research Projects & Grants

Internal

• MRSA Nare Testing in Pediatric Pneumonia Patients, Role: Investigator, LLU Dept. of Pediatrics, (01/2024) Status: Approved
• Impact of 24/7 Pharmacist-driven Interventions of Rapid Diagnostic Testing (RDT) for Treatment of Staphylococcus aureus Bloodstream Infections in Pediatric Patients, Role: PI, LLU Dept. of Pharmacy Practice, (10/2023) Status: Approved
• Impact of Verigene and 24/7 Pharmacist-driven Interventions of Rapid Diagnostic Testing for Treatment of Gram-negative Bloodstream Infections in Pediatric Patients (VERI-24/7 GNB PEDS), Role: PI, LLU Dept. of Pharmacy Practice, (11/2022) Status: Approved
• Assessment of nafcillin-associated phlebitis in pediatric patients, Role: PI, LLU Dept. of Pharmacy Practice, (09/2021) Status: Approved
• Clinical Outcomes in Patients Prescribed Antibiotics for Multisystem Inflammatory Syndrome in Children (MIS-C), Role: PI, LLU Dept. of Pharmacy Practice, (09/2021) Status: Approved
• Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 Infection: An Institutional Experience, Role: Investigator, LLU Dept. of Pediatrics, (03/2021) Status: Approved
• High risk Kawasaki disease case series, Role: Investigator, LLU Dept. of Pediatrics, (12/2019) Status: Approved
• Single vs. combination anti-methicillin-resistant Staphylococcus aureus (Anti-MRSA) antibiotics for the treatment of complicated Pneumonia in pediatric patients: A retrospective analysis, Role: PI, LLU Dept. of Pharmacy Practice, (11/2019 - 09/2024) Status: Completed
• Impact of Ceftazidime Duration on Neonatal Clinical Outcomes Across Various Weight Categories and Gestational Age, Role: PI, LLU Dept. of Pharmacy Practice, (10/2024) Status: Approved
• Impact of Diagnostic Stewardship Using Microbial Cell-Free DNA Testing on Antimicrobial Utilization in Pediatric Patients, Role: PI, LLU Dept. of Pharmacy Practice, (10/2024) Status: Approved